LabCompass

Khurram Liaqat

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Genomics and Rare DiseasesHearing, Cochlea, Tinnitus, GeneticsGenomic variations and chromosomal abnormalitiesGenetics and Neurodevelopmental DisordersCongenital heart defects research

Publications

48

Citations

408

Est. group size

~3

Recurring co-author estimate

Active years

10

Publishing since 2017

Research summary
AI-generated

Khurram Liaqat studies the genetic causes of inherited human diseases, working to identify the specific DNA variants (mutations) responsible for conditions such as hearing loss, rare syndromes affecting development, and infertility. Much of this work involves analyzing affected families, including consanguineous families in Pakistan, to pinpoint the genes behind these disorders. The research combines human genetic analysis with laboratory models such as zebrafish to confirm how these variants cause disease.

Genetics of hearing impairment (deafness)Rare and syndromic genetic disordersGene variant discovery in affected familiesMale infertility geneticsClinical and medical studies

Publication activity has been steady to slightly growing over the past decade, with a notable increase to around eight papers per year in 2023-2024.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 5.4/year recently
2017: 1 publication172018: 7 publications182019: 4 publications192020: 2 publications202021: 5 publications212022: 4 publications222023: 8 publications8232024: 8 publications8242025: 6 publications252026: 1 publication26
Recent publications
Publishes in
  • Journal of Human Genetics×7
  • Genetics in Medicine Open×5
  • Genetic Testing and Molecular Biomarkers×3
  • Clinical Genetics×3
  • Genes×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile